The province of Holguín, although with fewer positive cases of dengue and COVID-19 reported in the last week, maintains a worrying epidemiological situation, for which it is necessary to continue with prevention measures and increase control and supervision in the communities as the main alternative to avoid getting sick.
The Provincial Scientific Conference on Stomatology, Odontos-2022, will be held in-person from September 30 to October 4 in Holguín, with the aim of promoting the exchange of experiences and scientific results among specialists and students from the territory.
The president of the BioCubaFarma Biotech Conglomerate Eduardo Martinez announced the advancement in the development of a vaccine against Dengue Fever and the set up of a diagnostic system to detect the disease as the first symptoms appear.
The Mexican government announced the purchase of 9 million doses of the Cuban vaccine Abdala to immunize children between 5 and 11 years of age against Covid-19.
The main results achieved and the development prospects of the Cuban Biotechnological and Pharmaceutical Industries Group (BioCubaFarma), was the topic addressed by its president, Dr. Eduardo Martínez, who heads a representation of the creators of the Cuban anti-COVID-19 vaccines, in visit to Holguín.